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ABSTRACT
Introduction: Focused extracorporeal shockwave
therapy (ESWT) has been demonstrated to
improve wound healing and skin regeneration
such as in burn wounds and scars. We
hypothesized that the combination of focused
ESWT and a daily gluteal muscle strength
program is superior to SHAM-ESWT and
gluteal muscle strength training in moderate
to severe cellulite.
Methods: This was a single-center, double-
blinded, randomized-controlled trial. For
allocation of participants, a 1:1 ratio
randomization was performed using opaque
envelopes for the concealment of allocation.
Eligible patients were females aged 18–65 years
with cellulite. The primary outcome parameter
was the photo-numeric Cellulite Severity Scale
(CSS) determined by two blinded, independent
assessors. The intervention group (group A)
received six sessions of focused ESWT (2,000
impulses, 0.35 mJ/mm2, every 1–2 weeks) at
both gluteal and thigh regions plus specific
gluteal strength exercise training. The control
group (group B) received six sessions of SHAM-
ESWT plus specific gluteal strength exercise
training.
Results: The CSS in group A was 10.9 ± 3.8
(mean ± SE) before intervention and 8.3 ± 4.1
after 12 weeks (P = 0.001, 2.53 improvement,
95% confidence interval (CI) 1.43–3.62). The
CSS in group B was 10.0 ± 3.8 before
intervention and 10.1 ± 3.8 after 12 weeks
(P = 0.876, 95% CI 1.1–0.97). The change of
the CSS in group A versus group B was
significantly different (P = 0.001, -24.3 effect
size, 95% CI -36.5 to -12.1).
ClinicalTrials.gov identifier: NCT00947414.
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Conclusion: The combination of non-invasive,
focused ESWT (0.35 mJ/mm2, 2,000 impulses, 6
sessions) in combination with gluteal strength
training was superior to gluteal strength
training and SHAM-ESWT in moderate to
severe cellulite in terms of the CSS in a
3-month perspective. Long-term results have
to be evaluated in terms of the sustainability of
these effects.
Keywords: Aesthetics; Body contouring;
Cellulite; Dermatology; Extracorporeal shock
wave therapy; Strength training
INTRODUCTION
Cellulite is a widespread problem involving the
buttocks and thighs of the female-specific
anatomy [1]. The higher number of fat cells
stored in female fatty tissue in contrast to males,
the gender-specific dimorphism with subdermal
septae orientated orthogonally toward the skin,
and the aging process of connective tissue lead
to an imbalance between lipogenesis and
lipolysis with subsequent large fat cells bulging
the skin [1]. Recently, a case–control study in 15
lean women suffering from cellulite, and age-
and body mass index (BMI)-matched controls
identified significantly reduced adiponectin
expression using reverse transcription
polymerase chain reaction among the cellulite-
affected patients [2]. Cellulite appears to
potentially impair quality of life of affected
females substantially. It appears that younger
females affected by cellulite suffer more in terms
of impaired quality of life than more mature
females [3].
Non-randomized clinical data suggest that
extracorporeal shock wave therapy (ESWT) is
beneficial in terms of improved skin elasticity
and revitalizing dermis in females with cellulite
[4, 5]. Potentially, a direct effect on the
associated lymphedema is a further potential
consequence of ESWT application in cellulite. A
recent Korean prospective clinical trial
evaluated the effect of four ESWT sessions
(0.056–0.068 mJ/mm2, 2,000 impulses, ESWT
device from Dornier AB2) within 2 weeks in
patients suffering from secondary lymphedema
[6]. Both the circumference and the thickness of
the skin fold of the affected region were
significantly reduced by as much as 37% in
line with a pain reduction on the visual
analogue scale [6]. In systemic sclerosis, ESWT
is able to again improve pain and the Rodnan
skin score for skin wellness [7].
To date, a limited number of non-controlled
studies (two Level III [4, 8] and two Level IV
studies [9, 10]) examined the effect of ESWT on
cellulite with various outcome measures
(Table 1).
Recently, a small size (n = 25) randomized-
controlled trial (RCT) with large confidence
intervals (CIs) has been published (level 2
evidence) [11]. The trial involved six sessions
over 4 weeks using the STORZ D-ACTOR 200
by Storz Medical (Ta¨gerwilen, Switzerland)
improved depressions, elevations, roughness,
and elasticity within 3 months.
Beyond the aforementioned RCT [11], with
small sample size and large confidence
intervals, we do not have any high-level 1b
evidence to support the use of focused ESWT for
non-invasive body contouring in cellulite. In
addition, we do not know whether or not and if,
to what extent the validated photo-numeric
Cellulite Severity Scale (CSS) is changed by six
sessions of focused ESWT. Currently, we do not
have any high-level 1b evidence regarding the
effect of gluteal home-based strength training
with or without focused ESWT on the clinical
outcome in cellulite in terms of digital images,
microcirculation and patient self-reported
assessment. Given these facts we sought to
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overcome these issues and performed a double-
blinded, RCT providing level 1b evidence on the
use of focused ESWT in addition to daily gluteal
strength training in various degrees of cellulite.
We hypothesized that the combination of
ESWT and a daily gluteal muscle strength
program is superior to SHAM-ESWT and a
gluteal muscle strength program in cellulite.
METHODS
The study protocol was composed according to
the most recent CONSORT 2010
recommendations for transparent reporting of
RCTs [12, 13]. The study protocol according to
the CONSORT recommendations has been
published previously [14].
Ethics and Trial Registration
This RCT was approved in May 22, 2009 by the
ethics institutional review board at Hannover
Medical School, Germany, under the German title
‘‘Stosswellentherapie und Krafttraining zur
Therapie der Cellulite—eine randomsiert-
kontrollierte Studie’’ (Nr. 5206). The study is
internationally registered at ClinicalTrials.gov
with ClinicalTrials.gov identifier: NCT00947414.
All procedures followed were in accordance
with the ethical standards of the responsible
committee on human experimentation
(institutional and national) and with the
Helsinki Declaration of 1975, as revised in 2000
and 2008. Informed consent was obtained from
all patients for being included in the study and for
the publication of patient photographs.
Study Design
This was a single-center, double-blinded, RCT
with a 1:1 parallel group randomization.
Participants
The mean age of the enrolled participants was
41.4 years in the intervention group and
45.0 years in the control group. BMI
(mean ± SE) was 24.2 ± 3.2 kg/m2 in the
intervention group and 25.3 ± 4.5 kg/m2 in
the control group.
Eligible patients were females aged between
18 and 65 years with documented cellulite 0 to
3 according to the Nu¨rnberger Mu¨ller score [1].
Exclusion criteria were the following: suspected
or evident pregnancy, no cellulite, no informed
consent, and age under 18 years or above
65 years. Patients were recruited by
advertisements in local regional newspapers
and via the Internet. The patient enrollment
flow chart according to the CONSORT
statement is outlined in Fig. 1.
Interventions
In CelluShock-2009 patients were randomly
assigned with a 1:1 ratio to either ESWT with
0.35 mJ/mm2 in the intervention group or
0.01 mJ/mm2 in the SHAM-ESWT group. Both
groups additionally participated in a home-
based, daily gluteal thigh exercise program.
The intervention group received six sessions
of ESWT (every 1–2 weeks) with focused shock
waves (2,000 impulses, 0.35 mJ/mm2, Fig. 2)
plus home-based, daily gluteal strength
exercises (Figs. 3, 4). The control group
received six sessions of SHAM-ESWT (2,000
impulses, 0.01 mJ/mm2, every 1–2 weeks) plus
home-based, daily gluteal strength exercises.
Extracorporeal shock wave therapy was applied
using a STORZ focused Duolith machine
(Taegerwilen, Suisse) as acoustic wave
treatment.
In order to increase the motivation of the
participating females, especially in terms of
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follow-up, we added a daily, home-based gluteal
strength exercise program. Twice a day (in the
morning and the evening), two different
exercises focusing on the gluteal muscles
involving the piriformis, the gemelli, and the
gluteal muscles were performed with 15
repetitions for each leg (Figs. 1, 2). The
compliance to the daily gluteal workout
program was noted in a exercise log to
improve and supervise participants’
compliance, respectively.
Primary and Secondary Outcome
Measures
The primary endpoint, with respect to efficacy
of the combined ESWT and gluteal strength
exercises versus SHAM-ESWT and the same
Fig. 1 CONSORT patient ﬂow chart. Modiﬁed with permission from Knobloch et al. [14]
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gluteal strength exercise program, was the
change on digital photographs 3 months after
the last ESWT treatment assessed by the
validated CSS [15]. This provided reliable,
comprehensive, and reproducible results.
Cellulite severity may be classified according
to the result of this assessment in the CSS in
three degrees, as described in Table 2.
The classification was performed based on
standardized photographs taken by a
professional medical photographer at baseline
and 12 weeks after the last ESWT treatment in
both groups. The assessment of the anonymous
digital images was carried out by two blinded
assessors who were not aware of either the study
arm or the fact that it is a baseline or a follow-up
photograph taken 12 weeks after the last ESWT
treatment in both groups.
In order to overcome the problems of
interpretation associated with multiplicity of
analyses we decided to choose the
aforementioned clinical endpoint which is a
visual one as the primary endpoint and results
as secondary endpoints in CelluShock.
Secondary endpoints of the CelluShock RCT
were as follows: change of circumference of the
thigh (cm), skin elasticity using the Cutometer
(Cutometer MPA 580, Kosmetik Konzept KOKO
GmbH & Co KG, Leichlingen, Germany) [16–
19], and self-assessment of the success on a
visual analogue scale 0–10 (0 = no change,
10 = fully satisfied).
All patients were measured at baseline and
after 12 weeks regarding the primary and all
secondary endpoints.
Power Calculation
To detect at least a change of two points in the
CSS of cellulite, with a two-sided, 5%
significance with an 80% power, a sample size
of 26 participants with an estimated drop-out
rate of 15% was calculated. This was done prior
to the start of trial.
Table 2 Cellulite Severity Scale of mild, moderate or
severe degree




Fig. 2 Placement of the shockwave probe from distal to
proximal on both thighs
Fig. 3 First exercise (15 repetitions per leg twice a day
over 12 weeks)
Fig. 4 Second exercise (15 repetitions per leg twice a day
over 12 weeks)
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Randomization and Allocation Sequence
For allocation of participants, a 1:1 ratio
randomization was performed using opaque
envelopes for the concealment of allocation.
The allocation sequence was concealed from the
researcher (BJ) enrolling and assessing
participants in sequentially numbered,
opaque, sealed envelopes [20].
Blinding
Blinding was achieved for all participants
enrolled in the trial, the photographer taking
the digital images for the primary outcome
measure, the two assessors of the outcome
measures, all additional health care providers,
and for the analyst from the biometrical
department. Only one researcher (BJ) was
aware of the group assignment performing the
randomization and the ESWT.
The assessment of the primary and
secondary outcomes was performed by blinded
assessors independently from each other,
unaware whether the digital image displayed
was before or after therapy or with group
(intervention or control group) was
randomized.
Statistical Analysis
The primary endpoint was change of CSS
assessed on digital, standardized photographs
by two independent expert examiners.
Student’s t test was applied for parametric
data, the Wilcoxon test for non-parametric
data, and a level of P\0.05 was reported as
significant. An intention-to-treat analysis was
applied. SPSS (IBM Corp., New York, USA) was
used to carry out the analysis.
CONSORT Flow Chart
Figure 1 highlights the patient flow throughout




The CSS (mean ± SE) in the intervention group
was 10.9 ± 3.8 before and 8.3 ± 4.1 after the
combined ESWT and strength exercise
Fig. 6 Improvement of the Cellulite Severity Score from
12 to 2 in a female patient suffering from cellulite before
and 3 months after six sessions of focused extracorporeal
shockwave therapy (0.35 mJ/mm2)
Fig. 5 Improvement of the Cellulite Severity Score from
15 to 7 in a female patient suffering from cellulite before
and 3 months after six sessions of focused extracorporeal
shockwave therapy (0.35 mJ/mm2)
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intervention (P = 0.001, 2.53 improvement
(?24%), 95% CI 1.43–3.62) (Figs. 5, 6, 7, 8, 9,
10; Table 3). The CSS in the control group was
10.0 ± 3.8 before and 10.1 ± 3.8 after the
SHAM-ESWT and strength exercise
intervention (P = 0.876, 95% CI -1.1 to 0.97).
The change of the CSS in the intervention
group versus the control group was significantly
different (P = 0.001, -24.3 effect size, 95%
-36.5 to -12.1).
The results for the five items of the CSS, the
cutometer data, and the thigh circumferences
are reported below; all values are given as
mean ± SE unless otherwise stated.
Number of Depressions
The number of depressions in the intervention
group was 2.2 ± 0.8 at baseline and 1.8 ± 0.9 at
follow-up (P = 0.001, improvement 0.41, 95% CI
0.17–0.65). The number of depressions in the
control group was 2.0 ± 0.8 at baseline and
2.0 ± 0.7 at follow-up (P = 0.534, 95% CI -0.30
to 0.16). The change of the number of depressions
in the intervention versus the control group was
significantly different (P = 0.012, -20.0 effect
size, 95% CI -34.8 to -4.4).
Depth of Depressions
The depth of depressions in the intervention
group was 2.2 ± 0.8 at baseline and 1.6 ± 0.8 at
Fig. 7 Improvement of the Cellulite Severity Score from
10 to 6 in a female patient suffering from cellulite before
and 3 months after six sessions of focused extracorporeal
shockwave therapy (0.35 mJ/mm2)
Fig. 8 No signiﬁcant improvement of the Cellulite
Severity Score from 13 to 11 in a female patient suffering
from cellulite before and 3 months after six sessions of
sham extracorporeal shockwave therapy (0.01 mJ/mm2,
control group)
Fig. 9 No improvement of the Cellulite Severity Score
from 4 to 5 in a female patient suffering from cellulite
before and 3 months after six sessions of sham extracor-
poreal shockwave therapy (0.01 mJ/mm2, control group)
Fig. 10 Change of the Cellulite Severity Score before and
3 months after six sessions of either focused extracorporeal
shockwave therapy (ESWT) (0.35 mJ/mm2, intervention
group) or SHAM-ESWT (0.01 mJ/mm2, control group)
150 Dermatol Ther (Heidelb) (2013) 3:143–155
123
follow-up (P = 0.001, 0.61 improvement, 95%
CI 0.39–0.84). The depth of depressions in the
control group was 2.0 ± 0.8 at baseline and
2.0 ± 0.7 at follow-up (P = 1.0, 95% CI -0.24 to
0.24). The change of the depth of depressions in
the intervention group versus the control group
was significantly different (P = 0.001, -31.3
effect size, 95% CI -46.0 to -16.6).
Morphological Appearance of Skin Surface
Alterations
The morphological appearance of skin surface
alterations in the intervention group was
2.2 ± 0.8 at baseline and 1.6 ± 0.8 at follow-up
(P = 0.001, 0.6 improvement, 95% 0.36–0.8).
The morphological appearance of skin surface
alterations in the control group was 1.9 ± 0.8 at
baseline and 1.9 ± 0.6 at follow-up (P = 0.837,
95% CI -0.20 to 0.25). The change of the
morphological appearance of skin surface
alterations in the intervention group versus
the control group was significantly different
(P = 0.007, -16.6 effect size, 95% CI -28.7 to
-4.6).
Grade of Laxity, Flaccidity or Sagging Skin
The grade of laxity, flaccidity or sagging skin in
the intervention group was 2.2 ± 0.8 at baseline
and 1.6 ± 0.8 at follow-up (P = 0.001, 0.5
improvement, 95% CI 0.27–0.73). The grade of
laxity, flaccidity or sagging skin in the control
group was 2.0 ± 0.9 at baseline and 2.1 ± 0.8 at
follow-up (P = 0.516, 95% CI -0.34 to 0.17).
The change of the grade of laxity, flaccidity or
sagging skin in the intervention group versus
the control group was significantly different
(P = 0.001, -25.1 effect size, 95% CI -39.6 to
-10.6).
Classification Scale by Nu¨rnberger
and Mu¨ller
The classification scale by Nu¨rnberger and
Mu¨ller in the intervention group was 2.2 ± 0.8
at baseline and 1.8 ± 0.9 at follow-up
(P = 0.001, 0.5 improvement, 95% CI 0.3–0.8).
The classification scale by Nu¨rnberger and
Mu¨ller in the control group was 2.1 ± 0.8 at
baseline and 2.1 ± 0.7 at follow-up (P = 1.0,
95% CI -0.22 to 0.22). The change of the
classification scale by Nu¨rnberger and Mu¨ller in
the intervention group versus the control group
was significantly different (P = 0.043, -24.4
effect size, 95% CI -37.7 to -11.1).
Change of Circumference of the Thigh
and Body Mass Index
The change of thigh circumference in the
intervention group was 61.5 ± 6.2 cm at
baseline to 61.0 ± 5.9 cm at follow-up
(P = 0.760, 95% CI -2.91 to 3.97). There was
Table 3 Number of patients in each group according to the Cellulite Severity Scale in the intervention and the control
group prior and after the intervention
Cellulite Severity Scale Intervention group Control group
Baseline Post-intervention Baseline Post-intervention
1–5 (mild) 4 6 3 2
6–10 (moderate) 8 12 9 12
11–15 (severe) 13 7 9 7
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no change of thigh circumference in the control
group (61.6 ± 6.9 cm) at baseline versus follow-
up (61.6 ± 6.9 cm; P = 0.996; 95% CI -4.28 to
4.31). Pre- and post-treatment body weight
index did not change in either group
significantly beyond 3%.
Skin Elasticity Using the Cutometer
The skin elasticity in the intervention group
was 14.1 ± 2.5% at baseline and 14.1% ± 1.6 at
follow-up (P = 0.963; 95% CI -1.22 to 1.16).
The skin elasticity in the control group was
14.4% ± 1.8 at baseline and 14.1% ± 1.9 at
follow-up (P = 0.676; 95% CI -0.91 to 1.38).
DISCUSSION
The combination of focused ESWT (0.35 mJ/
mm2, 2,000 impulses, 6 sessions) in
combination with gluteal strength training
was superior to a gluteal strength training
alone in terms of the CSS in a 3-month
perspective. The significant mean
improvement was 24% in the intervention
group in contrast to the control group, a
clinically meaningful difference. Second, the
SHAM-ESWT and the gluteal strength training
were not able to change the CSS.
The strengths of this double-blinded,
randomized clinical trial are the independent
assessment by two expert examiners who were
blinded to both the patients and the group
allocation. Both experts assessed the digitalized
standardized photographs independently and the
mean of both assessments was applied. Second,
this is the first registered, double-blinded,
randomized clinical trial to assess the effects of a
gluteal strength training and the combination
with focused ESWT. Third, standardized
photographs were taken by a clinical
photographer independently from the study
team. Fourth, the control group received SHAM-
ESWT (0.01 mJ/mm2, 2,000 impulses, 6 sessions)
which did not appear to have any clinical effect in
terms of the CSS at all, with identical values before
and after the intervention.
However, to date we cannot estimate the
long-term efficacy and sustainability of the
aforementioned clinical effects in a perspective
of one or more years. It is possible that, after a
year, an additional treatment might be
warranted, such as a touch-up procedure. In
our personal experience, select cases might
benefit even longer than 1 year from a set of
six focused shockwave sessions, but this is only
a non-controlled observation.
The results of this randomized clinical study
should be discussed in detail. The CSS is a
validated photo-numeric Cellulite Severity
Scale, which has been published in 2009 by
Dr. Hexsel and coworkers [15]. Beyond the well-
known Nu¨rnberger and Mu¨ller score ranging
from 0 to 3, this validated score appears to
better reflect even modest to small changes of a
given therapeutic intervention. The CSS has a
high intraclass correlation coefficient of 0.9 or
more and ranges from 1 to 15. Three clinical
cellulite severity grades have been proposed by
Hexsel et al. [15] (Table 2). Given our patients,
we included the majority of patients with
moderate to severe degrees of cellulite. This is
partially reflected by the mean age beyond
40 years and the BMI beyond 24.2 kg/m2 in
both groups.
As far as the underlying mechanisms of the
evident improvements in the CSS are
concerned, a ‘‘mechanical’’ response might be
evident as well as a ‘‘regenerative’’ response of
the afflicted skin.
In terms of the ‘‘mechanical’’ perspective,
one might speculate that the focused
extracorporeal shockwave has somewhat
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disrupted either the fat components or the
septae or both, which might lead to a
smoothening of the afflicted skin. MR imaging
has shown that fibrous septa are visualized in
97% of the area with cellulite depressions,
which are markedly thickened in cellulite
afflicted areas [21]. Shockwave energy might
have weakened the fibrous septae and thus the
afflicted skin became smoother.
Reduction of lymphedema is a second
potential underlying mechanism. Recently, a
significant reduction of lymphedema was
reported clinically following four ESWT sessions
in females with secondary lymphedema
following breast cancer treatment [6]. In animal
experiments ESWT and the vascular endothelial
growth factor (VEGF-C) hydrogel appear to
exert a synergistic effect in promoting
lymphangiogenesis [22].
On the other hand, ESWT might somewhat
influence mesenchymal stem cells. There is
evolving experimental data suggesting that
shockwave therapy activation pathways in
adipose-derived stem cells [23]. Clinically,
diseased skin appears to normalize following
shockwave treatment such as in progressive
systemic sclerosis with an up regulation of
endothelial progenitor cells and circulating
endothelial cells [24].
Energy flux density of the focused ESWT is
another issue to concern. We used low to
medium energy flux densities of 0.35 mJ/mm2
with 1,000 impulses on each thigh with 4 Hz.
To date, we do not know in controlled trials
whether potentially higher energy flux densities
such as up to 1.24 mJ/mm2 might be even more
beneficial in terms of the potential disruption of
the fibrous septae in the cellulite-afflicted areas.
On the other hand, stem-cell activation might
be achieved by rather low-energy flux densities
in regard of the aforementioned potential
underlying ‘‘regenerative’’ mechanisms.
To date, only small size, controlled trials
with wide CIs have been published [7, 25]. We
tried to overcome the methodological
shortcomings of previous trials in CelluShock-
2009. In regard to different techniques, there
are evolving clinical data that, for example, low-
level laser therapy with 532 nm wave lengths
appears to improve cellulite in a double-blind,
placebo-controlled, randomized trial [26].
1,064 nm Nd:YAG laser appears to improve
mild to moderate cellulite also [27].
Radiofrequency is able to reduce cellulite in a
randomized trial [28].
Limitations
Given our randomized, double-blinded clinical
trial, some limitations have to be considered
when interpreting our data. First, the extent of
cellulite reflected by digital unprocessed images
assessed by two independent examiners was
chosen to overcome some types of biases.
However, a digital image does not necessarily
reflect or even replace a clinical examination
including a pinch test. However, we sought to
address as objective as possible the outcome
based on digital images. Those images were
produced by a clinical plastic surgical
professional photographer under the very
same circumstances to overcome issues such as
angle of the photograph, lighting, among
others. To date, we can only report the short-
term results 3 months following ESWT. We do
not know the long-term effects in terms of
efficacy and sustainability of six sessions of
focused ESWT in cellulite to date.
CONCLUSION
The combination of focused ESWT (0.35 mJ/
mm2, 2,000 impulses, 6 sessions) with gluteal
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strength training was superior to SHAM-ESWT
and gluteal strength training in moderate to
severe cellulite in terms of the CSS in a RCT. The
mean improvement was 24% in the
intervention in contrast to the control group.
Second, the SHAM-ESWT and gluteal strength
training were not able to change the CSS in a
3-month perspective. Long-term data are
warranted to elucidate the sustainability of the
aforementioned clinical effects.
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